Contains 30 transdermal patches of Rivastigmine 4.6 mg, designed for continuous release over 24 hours.
Manufactured by Mylan Pharmaceuticals, ensuring high quality and efficacy.
Generic name: Rivastigmine, a parasympathomimetic (cholinergic agent) used in the treatment of mild to moderate dementia in Alzheimer's and Parkinson's disease.
Dosage form: Patch, offering an alternative for patients who have difficulty swallowing pills.
Each patch is latex-free, catering to patients with latex allergies.
Designed for easy application and removal, enhancing patient comfort and adherence to treatment.
